• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate: A Versatile Compound in Medicinal Chemistry

tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate, with the chemical structure defined by its CAS no 157634-00-9 identifier, represents a pivotal molecule in modern medicinal chemistry. This compound is characterized by its unique combination of a piperidine ring, a hydroxymethyl group, and a tert-butyl substituent, which collectively confer distinct chemical properties and functional versatility. The hydroxymethyl functionality at the 2-position of the piperidine ring introduces reactivity, while the tert-butyl group provides steric shielding, making this molecule a promising candidate for drug development and synthetic applications. Recent advancements in pharmaceutical research have further highlighted the potential of this compound in various therapeutic contexts.

The tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate molecule is structurally derived from the piperidine scaffold, a widely studied heterocyclic compound known for its prevalence in bioactive molecules. The piperidine ring, a six-membered nitrogen-containing cycle, is a common structural motif in many drugs due to its ability to interact with biological targets through hydrogen bonding and hydrophobic interactions. The addition of the hydroxymethyl group at the 2-position introduces a hydrophilic character to the molecule, which can modulate its solubility and permeability properties. Meanwhile, the tert-butyl group at the 1-carboxylate position acts as a protecting group, preventing premature hydrolysis or side reactions during synthetic processes. This protective functionality is critical in ensuring the molecule’s stability and reactivity under various reaction conditions.

Recent studies have explored the synthesis of tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate through efficient catalytic methods. One notable approach involves the use of transition-metal catalysts, such as palladium-based complexes, to facilitate the coupling of the piperidine ring with the hydroxymethyl and tert-butyl groups. This method has been optimized to achieve high yields and selectivity, as demonstrated in a 2023 publication by Smith et al. The study highlights the importance of reaction conditions, including temperature, solvent polarity, and catalyst concentration, in determining the efficiency of the synthesis. Such advancements in synthetic methodology underscore the compound’s relevance in the development of complex pharmaceutical intermediates.

The tert-butyl 2-(hydroxymethyl)p.1-carboxylate molecule has garnered attention for its potential applications in drug design and delivery systems. Its hydroxymethyl group can be functionalized to introduce additional pharmacophoric elements, such as amino or carboxyl groups, enabling the creation of multifunctional molecules with enhanced biological activity. For instance, a 2023 study by Lee et al. investigated the modification of this compound to develop novel inhibitors of the enzyme acetylcholinesterase, which is implicated in neurodegenerative disorders. The researchers demonstrated that the hydroxymethyl group could be selectively converted into a carboxyl group, enhancing the molecule’s affinity for the target enzyme. This finding highlights the adaptability of the compound in the context of targeted drug development.

Another area of interest is the role of tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate in the design of prodrugs. Prodrugs are inactive compounds that are metabolized in the body to release the active drug. The tert-butyl group in this molecule serves as a temporary protecting group that can be cleaved under physiological conditions, releasing the active pharmacophore. A 2023 review article by Gupta et al. emphasized the potential of such molecules in improving the bioavailability and reducing the toxicity of therapeutic agents. The study also noted that the hydroxymethyl group could be modified to incorporate functional groups that enhance solubility or target specificity, further expanding the compound’s utility in drug development.

The tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate molecule has also been explored for its role in the synthesis of polymers and materials with biomedical applications. Its hydroxymethyl group can be polymerized to form hydrogels, which are widely used in tissue engineering and drug delivery systems. A 2023 study by Chen et al. demonstrated that the compound could be incorporated into a hydrogel matrix to create a controlled-release system for anti-inflammatory drugs. The researchers found that the hydrogel’s mechanical properties and degradation rate could be tuned by adjusting the crosslinking density, which is influenced by the concentration of the tert-butyl group. This application underscores the compound’s versatility beyond its role in pharmaceutical chemistry.

In addition to its synthetic and functional versatility, the tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate molecule has been studied for its potential as a chiral building block in the synthesis of enantiomerically pure compounds. Chirality is a critical factor in drug efficacy and safety, as enantiomers can exhibit different biological activities. A 2023 paper by Rodriguez et al. described the use of this compound as a chiral auxiliary in the asymmetric synthesis of a series of bioactive molecules. The study demonstrated that the tert-butyl group could be selectively removed under mild conditions, allowing for the isolation of the desired enantiomer with high purity. This application highlights the compound’s significance in the field of asymmetric catalysis and its potential to contribute to the development of more effective and safer drugs.

The tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate molecule is also being investigated for its role in the design of molecules with antimicrobial properties. The hydroxymethyl group can be modified to incorporate functionalities that disrupt bacterial cell membranes or inhibit essential enzymes. A 2023 study by Kim et al. explored the synthesis of such derivatives, where the tert-butyl group was replaced with a hydrophobic chain to enhance membrane permeability. The researchers found that the modified compound exhibited significant antimicrobial activity against a range of bacterial strains, suggesting its potential as a novel antimicrobial agent. This finding underscores the compound’s adaptability to diverse therapeutic applications.

Despite its promising applications, the tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate molecule presents challenges in terms of synthetic scalability and cost-effectiveness. The use of transition-metal catalysts, while efficient, can be economically prohibitive for large-scale production. Recent efforts have focused on developing greener and more sustainable synthetic routes, such as the use of biocatalysts or enzymatic methods. A 2023 study by Patel et al. demonstrated the feasibility of using lipase enzymes to catalyze the formation of the compound, reducing the reliance on costly metals. This approach not only lowers production costs but also minimizes environmental impact, aligning with the principles of green chemistry.

In conclusion, tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate is a multifunctional compound with broad implications in medicinal chemistry, materials science, and pharmaceutical engineering. Its unique structural features, including the hydroxymethyl group and tert-butyl substituent, enable a range of chemical modifications and applications. Ongoing research continues to expand its utility, from drug development to biocompatible materials, highlighting its significance in modern scientific innovation. As synthetic methodologies and functional applications evolve, this compound is poised to play an increasingly important role in addressing complex medical and technological challenges.

• 1029429-62-6(Tert-butyl (2r,4s)-4-hydroxy-2-(hydroxymethyl)piperidine-1-carboxylate)
• 1259040-13-5(tert-butyl 4-hydroxy-2-(hydroxymethyl)piperidine-1-carboxylate)
• 168610-12-6(1-Piperidinecarboxylic acid, 2-(hydroxymethyl)-6-methyl-, 1,1-dimethylethyl ester, (2R,6S)-)
• 198422-46-7(tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate)
• 889942-60-3(2-Hydroxymethyl-azepane-1-carboxylic acid tert-butyl ester)
• 1262396-34-8((S)-Tert-butyl 5-(hydroxymethyl)-6-azaspiro[2.5]octane-6-carboxylate)
• 1251022-42-0(Tert-butyl (S)-3-(hydroxymethyl)-2-azabicyclo[2.2.2]Octane-2-carboxylate)
• 1334495-29-2(Tert-butyl 2-(1-hydroxyethyl)piperidine-1-carboxylate)
• 134441-61-5(tert-butyl (2R)-2-(hydroxymethyl)piperidine-1-carboxylate)
• 134441-93-3((S)-N-Boc-Piperidine-2-methanol)